Balance Sheet - Enliven Therapeutics, Inc. (ELVN)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | |
|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 462.62 | 313.44 | 253.15 | 75.54 | 151.99 | 88.22 | 28.91 | 7.38 | 9.67 |
| Other current assets | 12.26 | 4.69 | 13.00 | 2.22 | 0.65 | 2.18 | 1.72 | 0.32 | 0.55 |
| Total current assets | 474.88 | 318.13 | 266.15 | 77.75 | 110.67 | 90.41 | 30.62 | 7.71 | 10.22 |
| Total non-current assets | 1.29 | 7.63 | 5.72 | 5.55 | 2.66 | 0.44 | 2.67 | ||
| Total assets | 476.17 | 325.76 | 271.87 | 83.30 | 113.33 | 90.84 | 33.30 | 7.71 | 10.22 |
| Total current liabilities | 16.57 | 15.92 | 25.89 | 9.72 | 5.75 | 6.25 | 4.20 | 1.83 | 0.83 |
| Total non-current liabilities | 0.11 | 0.00 | 0.07 | 150.41 | 0.71 | 0.16 | 0.18 | 32.19 | 0.66 |
| Total liabilities | 16.68 | 15.92 | 25.96 | 160.12 | 6.47 | 6.41 | 4.38 | 1.83 | 1.49 |
| Total stockholders' equity | 459.60 | 309.85 | 245.91 | -76.83 | 106.86 | 84.44 | -48.85 | -26.32 | -15.53 |
| Common shares outstanding | 57 | 47 | 36 | 6 | 8 | 4 | 4 | 4 | 4 |
Show Quarterly Balance Sheet
Balance Sheet - Enliven Therapeutics, Inc. (ELVN)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 452.40 | 462.62 | 477.57 | 490.50 | 289.56 | 313.44 | 291.83 | 312.39 | 320.50 | 253.15 | 263.48 | 277.87 | 292.10 | 75.54 | 92.97 | 60.34 | 72.90 | 151.99 | 102.84 | 66.77 | 75.59 | 88.22 | 96.09 | 106.28 | 105.87 | 28.91 | 0.00 | 0.00 | 0.00 |
| Other current assets | 10.74 | 12.26 | 5.12 | 5.12 | 4.76 | 4.69 | 5.16 | 5.74 | 16.70 | 13.00 | 5.13 | 5.31 | 5.90 | 2.22 | 2.07 | 3.92 | 5.63 | 0.65 | 3.16 | 4.59 | 4.77 | 2.18 | 3.62 | 4.32 | 3.95 | 1.72 | |||
| Total current assets | 463.14 | 474.88 | 482.68 | 495.62 | 294.32 | 318.13 | 297.00 | 318.13 | 337.20 | 266.15 | 268.61 | 283.18 | 298.00 | 77.75 | 88.23 | 64.26 | 78.53 | 110.67 | 106.00 | 71.36 | 80.36 | 90.41 | 99.71 | 110.59 | 109.82 | 30.62 | |||
| Total non-current assets | 1.72 | 1.29 | 8.19 | 8.27 | 8.25 | 7.63 | 8.43 | 8.92 | 5.58 | 5.72 | 5.44 | 5.33 | 4.86 | 5.55 | 2.57 | 0.41 | 3.07 | 2.66 | 1.03 | 1.11 | 1.33 | 0.44 | 0.46 | 0.72 | 0.51 | 2.67 | |||
| Total assets | 464.85 | 476.17 | 490.88 | 503.89 | 302.57 | 325.76 | 305.43 | 327.04 | 342.78 | 271.87 | 274.04 | 288.50 | 302.87 | 83.30 | 90.80 | 64.67 | 81.60 | 113.33 | 107.03 | 72.47 | 81.69 | 90.84 | 100.18 | 111.32 | 110.32 | 33.30 | |||
| Total current liabilities | 11.49 | 16.57 | 14.65 | 15.21 | 13.97 | 15.92 | 17.03 | 22.11 | 25.03 | 25.89 | 12.08 | 9.15 | 10.94 | 9.72 | 8.33 | 3.30 | 7.22 | 5.75 | 7.19 | 6.97 | 5.50 | 6.25 | 5.31 | 4.85 | 4.95 | 4.20 | |||
| Total non-current liabilities | 0.00 | 0.11 | 0.10 | 0.20 | 0.30 | 0.00 | 0.00 | 0.01 | 0.03 | 0.07 | 0.21 | 0.36 | 0.51 | 150.41 | 0.81 | 1.58 | 1.97 | 0.71 | 0.47 | 0.53 | 0.59 | 0.16 | 0.17 | 0.17 | 0.18 | 0.18 | |||
| Total liabilities | 11.49 | 16.68 | 14.75 | 15.42 | 14.27 | 15.92 | 17.03 | 22.11 | 25.07 | 25.96 | 12.29 | 9.51 | 11.45 | 160.12 | 9.14 | 3.30 | 9.19 | 6.47 | 7.65 | 7.50 | 6.09 | 6.41 | 5.48 | 5.02 | 5.13 | 4.38 | |||
| Total stockholders' equity | 453.37 | 459.60 | 476.12 | 488.47 | 288.30 | 309.85 | 288.40 | 304.93 | 317.71 | 245.91 | 261.75 | 278.99 | 291.42 | -76.83 | 81.65 | 61.36 | 72.41 | 106.86 | 99.37 | 64.97 | 75.59 | 84.44 | 94.70 | 106.30 | 105.19 | 28.92 | |||
| Common shares outstanding | 63 | 57 | 62 | 52 | 50 | 50 | 48 | 48 | 42 | 41 | 41 | 41 | 19 | 7 | 7 | 7 | 7 | 7 | 6 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |